On February 11, 2019, Brian M. Posner gave notice to Cellectar Biosciences, Inc. (the “Company”) of his resignation as Chief Financial Officer, effective March 8, 2019. The Company has initiated a search to identify and recruit a new candidate for the role of Chief Financial Officer.
In connection with his resignation, Mr. Posner acknowledged that his resignation did not result from any disagreement regarding the Company’s financial reporting or accounting policies, procedures, estimates or judgments.
As filed in the SEC 8-K current report
As Prepared for DeliveryI. IntroductionThank you to everyone for being here. It’s good to be…
Federal bank regulatory agencies today released a guide to support community banks in managing risks…
WASHINGTON – From May 6th to May 9th, Under Secretary of the Treasury for Terrorism…
As Prepared for DeliveryI. IntroductionGood afternoon. Thank you to the McCain Institute for the invitation…
WASHINGTON – Today the U.S. Department of the Treasury and Internal Revenue Service (IRS) released…
WASHINGTON — Today, the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC)…